Regeneron Awarded Injunctions Blocking Eylea Biosimilars
Regeneron Pharmaceuticals has secured a series of legal victories barring recently FDA approved biosimilars to its blockbuster eye drug, Eylea®,…
Regeneron Pharmaceuticals has secured a series of legal victories barring recently FDA approved biosimilars to its blockbuster eye drug, Eylea®,…
